VALLEY FORGE, Pennsylvania, Dec. 22 (TNSper) -- American Baptist Churches USA issued the following news release: American Baptist Churches of Vermont and New Hampshire Executive Minister Rev. Dale R. Edwards has announced his intent to retire on September 1, 2023. Edwards plans to work with the Region Board of Trustees and its Executive Committee to prepare for the transition over the coming months. Rev. Soozi Whitten Ford, interim associate general secretary for Regional Ministries, said, "Re  more

BOSTON, Massachusetts, Dec. 22 -- Massachusetts Attorney General Maura Healey issued the following news release: A Connecticut-based long-term care management company operating nursing homes across southern New England has agreed to pay $1.75 million and adopt a series of critical compliance measures in a settlement reached by Attorney General Maura Healey's Office. The settlement resolves a series of allegations, including that the company failed to meet the needs of nursing home residents exp  more

CHICAGO, Illinois, Dec. 22 (TNStalk) -- The Alzheimer's Association issued the following news release and letter: The Alzheimer's Association filed a formal request asking the Centers for Medicare & Medicaid Services (CMS) to provide full and unrestricted coverage for Food and Drug Administration (FDA)-approved Alzheimer's treatments. In its letter, the Association asked CMS to remove the requirements for Coverage with Evidence Development (CED) in its national coverage determination (NCD) for   more

DALLAS, Texas, Dec. 22 (TNSjou) -- The American Heart Association issued the following news release: Identifying early risks and treatments among children and mothers, continued health disparities and finding new ways to use medications already on the market are among some of the significant scientific research developments in the fight against heart disease and stroke that emerged in 2022. The American Heart Association, the largest non-governmental funder of heart and stroke related research   more

BOSTON, Massachusetts, Dec. 22 (TNSper) -- The Berkshire Bank issued the following news release: Berkshire Bank, a leading socially responsible community bank with financial centers in New England and New York, is pleased to announce Dan Shertzer as first vice president (FVP) and regional manager of its financial center network in eastern Massachusetts. "We are very excited to welcome Dan to our team," said Ryan Shorette, senior vice president and head of Retail Financial Center Banking. "He b  more

WASHINGTON, Dec. 22 -- Sen. Christopher Murphy, D-Connecticut, issued the following news release on Dec. 21, 2022, and letter: As Congress works to finalize the FY 2023 Omnibus appropriations package, U.S. Senator Chris Murphy (D-Conn.) and U.S. Representative Joe Courtney (D-Conn.-02), and the Connecticut and Rhode Island Congressional Delegations are pressing for additional funding to assist New England livestock feed producers and other farmers impacted by severe drought conditions. Today, C  more

MONTPELIER, Vermont, Dec. 22 -- The Vermont Agency of Natural Resources' Department of Environmental Conservation issued the following news on Dec. 21, 2022: the Department of Environmental Conservation (DEC) announced the issuance of the final Pretreatment Discharge permit by Watershed Management Division to Casella Waste for the continued authorization of the New England Waste Services of Vermont (NEWSVT) landfill in Coventry, Vermont to discharge (collect and transport) leachate to the Montp  more

BOSTON, Massachusetts, Dec. 22 (TNSrpt) -- The Institute for Clinical and Economic Review issued the following news release: * * * Evidence is rated as insufficient to differentiate the net health benefit between ublituximab and other monoclonal antibodies; analyses suggest ublituximab and all currently available monoclonal antibodies labeled for MS would achieve common thresholds for cost-effectiveness if priced between $16,500- $34,900 per year, a range far lower than current market prices n  more

AUGUSTA, Maine, Dec. 22 (TNSsro) -- The Maine Public Utilities Commission issued the following order (No. 2022-00091) on Dec. 21, 2022: * * * MAINE PUBLIC UTILITIES COMMISSION Standard Offer Bidding Procedure for Central Maine Power (all classes), Versant Power-Bangor Hydro District (all classes), and Versant Power-Maine Public District (all classes) ORDER CLARIFYING ORDERS DESIGNATING STANDARD OFFER PROVIDERS WITH RESPECT TO THE CMP and BHD LARGE CLASS BARTLETT, Chairman; DAVIS and SCULLY,   more

BEDFORD, New Hampshire, Dec. 22 -- The New Hampshire Housing Finance Authority issued the following agency statement on Dec. 21, 2022: * * * Financing for six multifamily housing developments in Concord, Hillsborough, Nashua and Rochester was recently approved by the New Hampshire Housing Board of Directors. Once constructed, these 341 new units will help meet the critical need for affordable rental housing for our state's workforce and other residents. The following projects will be funded t  more

SAN FRANCISCO, California, Dec. 22 (TNSjou) -- The University of California San Francisco campus issued the following news release: * * * First 10 Patients With Deadly Immune Deficiency Are Doing 'Amazing' * * * Ten young children born without functioning immune systems and lacking the ability to fight infections are on track for healthier lives thanks to a new gene therapy treatment pioneered at UC San Francisco, reports a Dec. 22 study in the New England Journal of Medicine. The children   more

CHAPEL HILL, North Carolina, Dec. 22 (TNSjou) -- The University of North Carolina School of Medicine issued the following news release: * * * Evan Dellon, MD, MPH, a professor in the Department of Medicine and director of the Center for Esophageal Diseases and Swallowing, co-leads effort to approve an allergy drug, dupilumab, for the treatment in adults and adolescents with eosinophilic esophagitis. * * * Eosinophilic esophagitis (EoE) is an allergic condition of the esophagus that is on the  more

HOUSTON, Texas, Dec. 22 (TNSjou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Dec. 21, 2022: * * * CodeBreaK 100 study demonstrates acceptable safety profile and encouraging results * * * In the Phase I/II CodeBreaK 100 trial, the KRAS G12C inhibitor sotorasib achieved meaningful anticancer activity with an acceptable safety profile in heavily pretreated patients with KRAS G12C-mutated metastatic pancreatic cancer, according to researchers at Th  more